Atlas Trials

AO GENERIUM

30 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch AO GENERIUM

RecordFirmDate
A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular Dystrophy (NCT07673809)AO GENERIUM2025-09-30
A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis. (NCT07155499)AO GENERIUM2024-10-07
A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Volunteers (NCT06488521)AO GENERIUM2024-06-20
An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease (NCT06497491)AO GENERIUM2023-12-12
An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis (NCT06488664)AO GENERIUM2023-07-25
Comparison of Complarate® (Tocilizumab Biosimilar) and Actemra® in Patients With Rheumatoid Arthritis (NCT06475508)AO GENERIUM2023-02-13
A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy Volunteers (NCT06494345)AO GENERIUM2023-01-15
A Safety, Pharmacokinetics and Pharmacodynamics Study of GNR-086 and Ilaris® in Healthy Volunteers (NCT06481189)AO GENERIUM2022-09-06
A Safety and Pharmacokinetic Study of Complarate (Tocilizumab Biosimilar) and Actemra® in Healthy Volunteers (NCT06481202)AO GENERIUM2022-04-11
Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients (NCT05492409)AO GENERIUM2022-03-28
Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis® (NCT04667039)AO GENERIUM2022-03-20
A Safety and Pharmacokinetics Study of Ustekinumab Biosimilar GNR-068 and Stelara® in Healthy Volunteers (NCT06481215)AO GENERIUM2022-03-11
Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema (NCT04898309)AO GENERIUM2021-12-01
A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II (NCT05208281)AO GENERIUM2021-11-30
Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP (NCT05220878)AO GENERIUM2021-09-09
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction (NCT05601999)AO GENERIUM2021-09-03
GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL (NCT04601584)AO GENERIUM2020-10-15
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies (NCT04544748)AO GENERIUM2020-07-22
Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19 (NCT04459325)AO GENERIUM2020-06-01
Safety and Pharmacokinetics of GNR-038 in Healthy Volunteers (NCT04557319)AO GENERIUM2020-03-10
A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers (NCT04539340)AO GENERIUM2020-02-28
Observational Study of Elizaria® in aHUS Patients (NCT04749810)AO GENERIUM2019-12-19
Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria® (NCT04671810)AO GENERIUM2019-06-13
A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation) (NCT04679103)AO GENERIUM2018-05-03
Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH (NCT04463056)AO GENERIUM2017-11-29

Track AO GENERIUM automatically

Every clearance here is in the API, with alerts when new ones post.